How many employees work at LeukoCare?
LEUKOCARE AG has approximately 68 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. LeukoCare’s total headcount has declined 36.0% from 106 employees in 2023 to 68 in 2026.
Is LeukoCare hiring right now?
No, LeukoCare is not actively hiring. LeukoCare had 0 active job postings in 2026, a 200.0% decline from 2025 — see job openings & hiring trends.
About LeukoCare’s Workforce
LEUKOCARE AG is a Biotech and Healthcare Services company that employs 68 people worldwide as of March 2026. It is the 3rd-largest by headcount among its peers. Founded in 2001, the company is headquartered in Aschaffenburg, Germany.
LeukoCare's workforce has declined 36.0% from 2023 to 2026, though it is up 1.2% year over year in 2026. It fell to a low of 54 in 2024 Q4 before recovering. Its workforce is concentrated most in Western Europe (98.5%), followed by North America (1.5%).
LeukoCare's functional groups are Finance and Operations (41.2%), Engineering (32.6%), and Sales and Marketing (26.2%), with Finance and Operations growing fastest (up 11.3%). The average salary is $88,478, highest in Western Europe at a median of $81,000, up 2.5% year over year in 2026.
LeukoCare's active job postings fell 200.0% in 2026 to 0. Overall employee sentiment is positive and broadly stable.
Sourced from Revelio Labs workforce data.
- Headquarters
- Aschaffenburg, Germany
- Founded
- 2001
- Industry
- Biotech and Healthcare Services
- Employees
- 68
- YoY
- +1.2% (+9)
As of March 2026
LeukoCare workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for LeukoCare. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsLeukoCare Annual Employee Count (2023-2026)
- LeukoCare had 68 employees in 2026, a 1.2% increase (+9) from 2025.
- LeukoCare had 66 employees in 2025, a 4.9% increase (+12) from 2024.
- LeukoCare had 54 employees in 2024, a 16.3% decline (-29) from 2023.
- LeukoCare had 83 employees in 2023, a 13.4% decline (-27) from 2022.
LeukoCare's total workforce has grown from 54 employees in 2024 to 68 in 2026. LeukoCare's headcount peaked at 106 in 2023 before declining in 2024 and recovering through 2025 and 2026.
LEUKOCARE AG quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 68 | +9 | +1.2% |
| 2025 | Q4 | 66 | +12 | +4.9% |
| 2025 | Q3 | 65 | +9 | +5.4% |
| 2025 | Q2 | 58 | -1 | +3.4% |
| 2025 | Q1 | 59 | -2 | +1.0% |
| 2024 | Q4 | 54 | -29 | -16.3% |
| 2024 | Q3 | 56 | -37 | -19.4% |
| 2024 | Q2 | 59 | -47 | -26.0% |
| 2024 | Q1 | 61 | -48 | -26.2% |
| 2023 | Q4 | 83 | -27 | -13.4% |
| 2023 | Q3 | 93 | -18 | -7.9% |
| 2023 | Q2 | 106 | +4 | +1.7% |
See LeukoCare's complete headcount history, including quarterly breakdowns.
Get the DataLeukoCare Employee Count by Region (2026)
Western Europe accounts for the largest share of LeukoCare's global workforce with approximately 99% of total employees, followed by North America.
LeukoCare employees by region
| Region | Employees | % of Total |
|---|---|---|
| Western Europe | 67 | 98.5% |
| North America | 1 | 1.5% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataLeukoCare Employee Count by Department (2026)
LeukoCare's employee groups are Finance and Operations (41.2%), Engineering (32.6%), and Sales and Marketing (26.2%).
LeukoCare employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 28 | 41.2% |
| Engineering | 22 | 32.6% |
| Sales and Marketing | 18 | 26.2% |
Compare LeukoCare's department mix to industry peers.
See Full DataLeukoCare Employee Salary by Region (2026)
LeukoCare's average employee salary is $88,478 globally. Employees in Western Europe receive the highest compensation.
LeukoCare median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Western Europe | $81,000 |
Unlock salary by role, level, and city — and compare to LeukoCare's industry peers.
Unlock Salary DataLeukoCare Job Openings and Hiring Trends (2023-2026)
- LeukoCare had 0 active job postings in 2026, a 200.0% decline (-1) from 2025.
- LeukoCare had 1 active job postings in 2025, a 200.0% increase (+1) from 2024.
- LeukoCare had 0 active job postings in 2024, a 0% no change from 2023.
- LeukoCare had 0 active job postings in 2023, a 200.0% decline from 2022.
- Hiring velocity in 2026: 0 new roles/month, down from 3 in 2025 and 0 in 2024.
LeukoCare's active job postings fell 200.0% in 2026 to 0.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataLeukoCare Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across LeukoCare's workforce based on public professional data. Overall sentiment is positive and has held steady year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Biotech and Healthcare Services Companies by Employee Count
Frequently Asked Questions About LeukoCare
- How fast is LeukoCare growing?
- In 2026, LeukoCare's headcount grew 1.2% to 68 employees, up from 59 in 2025.
- See the full headcount history
- Where are LeukoCare employees located?
- Most LeukoCare employees are based in Western Europe (98.5% of headcount), followed by North America.
- Explore where the workforce is based
- What is the average salary at LeukoCare?
- The average employee salary at LeukoCare is approximately $88.5k per year.
- Analyze the salary distribution
- How many new job postings does LeukoCare open per year?
- In Q1 2026, LeukoCare opened 0 new job postings. In 2025, LeukoCare opened 35 new job postings — about 3 per month.
- Track hiring trends by role
- When was LeukoCare founded and where is it headquartered?
- LeukoCare was founded in 2001 and is headquartered in Aschaffenburg, Germany.
- Compare LeukoCare to industry peers
Speak with a workforce expert about LeukoCare.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.